To find out more about subscribing to GeneWatch and having it delivered to your doorstep six times a year, just click here.


SEARCH >


RECEIVE CRG EMAIL >

PROGRAMS >

Genetic Determinism

Genetic Testing, Discrimination, and Privacy

Human Genetic Manipulation and Cloning

Biotechnology and Agriculture

Biowarfare

Genetic Bill of Rights

Women and Biotechnology

Other Genetic Issues

 

HUMAN GENETIC MANIPULATION AND CLONING

CRG's Position on Cloning
The CRG strongly opposes human reproductive cloning. We recognize the
importance of research in early development, and support vigorous
international discussions on the ethical and regulatory concerns that
such research should respect. This statement supercedes all prior CRG
statements on cloning.
Approved by the CRG Board in May 2004


Background Materials

Women and Biotechnology

Stem Cell Primer .pdf

Stem Cell Myths .pdf

What Your Mother Never Told You About Stem Cells .pdf

June 2001 Cloning Statement (also available in .pdf format)

Germline Manipulation Position Paper (also available in .pdf format)

History of Cloning Timeline 1938 - 1999

Articles

Egg Donation Dangers by Judy Norsigian, GeneWatch, October 2005

The Year of the Stem Cell: George Annas Talks About the Future of Stem Cell Research in America by Sujatha Byravan, GeneWatch, October 2005

Yuppie Eugenics by Ruth Hubbard and Stuart Newman, Z Magazine, March 2002

Embryo Stem Cells and Biobusiness at 20 by Stuart Newman, GeneWatch, November 2001

Human Cloning: Brave New Mistake by Sophia Kolehmainen, JD, Hofstra Law Review, Vol. 27 No.3

Don't Try to Engineer Human Embryos by Stuart Newman, St. Louis Post-Dispatch, 25 July 2000

"The Hazards of Human Developmental Gene Modification" by Stuart Newman, GeneWatch, July 2000

"Genetic Technologies Troubling" by Paul Billings, The Times Union, 16 March 1999


Legislative Materials

The Cloning Landscape: A Look at Pending Legislation by Doug Hunt, GeneWatch May 2002

Comments to the Food and Drug Administration, Biological Response Modifiers Advisory Committee, October 2002


CRG in the Press

"Gene Therapy Has Encountered Many Unexpected Obstacles," by David Lore, Columbus Dispatch, 15 October 2002

"US Panel Recommends Reopening Gene Therapy Trials," AFX, 11 October 2002

"Gene Trial Advised: Despite Illness, Panel Proposes Work Continue Because of Results in Other Cases," by Alice Dembner, Boston Globe, 11 October 2002

Resources

Our Bodies, Our Selves

Foundation on Economic Trends

Center for Genetics and Society

CRG
5 Upland Road, Suite 3 Cambridge, MA 02140
p: 617.868.0870
f: 617.491.5344

e: crg@gene-watch.org